Page 154 - Pharmacy Appeals 1/4/04 to 31/3/05

130 Financial statements

7. Provisions for liabilities and charges

Provisions Ex-RHA ELS CNST DHSC ELGP ELSGP
clinical

£0 0 0 s £0 0 0 s £0 0 0 s £0 0 0 s £0 0 0 s £0 0 0 s

Opening provision
55,751 1,002,628 38,247,332 2,592,424 193,635 207,462
for known claims
Opening provisions for IBNR 6 , 0 0 0 145,000 40,639,000 618,000 289,000 191,000
Restated1total provision

61,751 1,147,628 78,886,332 3,210,424 482,635 398,462
as at 1April 2021

Movement in known claims
Transfer between schemes 0 0 0 0 (193,635) 193,635

Provided in the year 1,198 38,279 8,408,657 221,273 0 481,934
Provision not required
(546) (18,744) (2,827,151) (91,359) 0 (159,697)
written back
Unwinding of discount 953 16,590 290,785 36,571 0 2,259

Change in discount rate 19,234 361,160 16,409,916 868,107 0 117,368
Provisions utilised
(1,265) (19,906) (2,213,856) (82,773) 0 (80,574)
in the year

Movement in known claims 19,574 377,379 20,068,351 951,819 (193,635) 554,925
Movement in IBNR

Transfer between schemes 0 0 0 0 (289,000) 289,000

Change in discount rate 0 68,768 24,463,000 285,027 0 5,000

Provided in the year (6 ,0 0 0 ) (33,768) (3,059,000) (256,027) 0 (147,000)

Movement in IBNR (6 ,0 0 0 ) 35,000 21,404,000 29,000 (289,000) 147,000
Closing provision for
75,325 1,380,007 58,315,683 3,544,243 0 762,387
known claims
Closing provisions for IBNR 0 180,000 62,043,000 647,000 0 338,000

Total provision as at
75,325 1,560,007 120,358,683 4,191,243 0 1,100,387
31 March 2022
Analysis of expected timing
of discounted cash flows2
Not later than one year 1,297 36,975 2,393,405 162,955 0 109,373

Later than one year and
5,422 125,467 10,005,727 611,766 0 327,042
not later than five years
Later than five years 68,606 1,397,565 107,959,551 3,416,522 0 663,972
Total provision as at
75,325 1,560,007 120,358,683 4,191,243 0 1,100,387
31 March 2022

The provisions relating to NHS Resolution's indemnity schemes are the only provisions made by NHS Resolution.

1The opening balance at 1 April 2021 has been increased by £2,457 million to reflect a prior period adjustment for

2020/21 in respect of the revaluation of the known claims provision. See Note 7.4 for further details of the revaluation.